The effect of intranasal and inhaled corticosteroids in healthy volunteers on the number of circulating lymphocytes and lymphocyte subsets

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 54, Issue 2, 1999, Pages 158-164

  Fokkens, W J ^a   Van de Merwe, J P ^a   Braat, J P ^a   Overbeek, S E ^a   Hooijkaas, H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Healthy volunteers; Human; Iatrogenic disease; Intrabronchial; Intranasal; Lymphopenia; Topical glucocorticosteroids

Indexed keywords

BUDESONIDE; FLUTICASONE PROPIONATE;

ADULT; ARTICLE; B LYMPHOCYTE; CORTICOSTEROID THERAPY; DRUG EFFECT; DRUG SAFETY; FEMALE; GROWTH RETARDATION; HUMAN; HUMAN EXPERIMENT; INHALATIONAL DRUG ADMINISTRATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTOPENIA; MALE; NORMAL HUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; RISK ASSESSMENT; T LYMPHOCYTE;

ADMINISTRATION, INHALATION; ADMINISTRATION, INTRANASAL; ADRENAL CORTEX HORMONES; ADULT; ANDROSTADIENES; BUDESONIDE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; MALE;

EID: 0032992749     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.1999.00747.x     Document Type: Article

References (12)

1. 1. Fokkens W, Godthelp T, Holm AF, Blom H, Kleinjan A. Allergic rhinitis and inflammation: the effect of nasal corticosteroid therapy. Allergy 1997;52 Suppl 36:29-32.
2. 2. Lipworth BJ. Clinical pharmacology of corticosteroids in bronchial asthma. Pharmacol Ther 1993;58:173-209.
3. 3. Jacobs M. Maintenance therapy for obstructive lung disease. How to achieve the best response with the fewest agents. Postgrad Med 1994;95:87-90,93-96,99.
4. 4. Hanania NA, Chapman KR, Kesten S. Adverse effects of inhaled corticosteroids [Review]. Am J Med 1995;98:196-208.
5. 5. Boorsma M, Andersson N, Larsson P, Ullman A. Assessment of the relative systemic potency of inhaled fluticasone and budesonide. Eur Respir J 1996;9:1427-1432.
6. 6. Wihl J-Å, Andersson K-E, Johansson S-Å. Systemic effects of two nasally administered glucocorticosteroids. Allergy 1997;52:620-626.
7. 7. Pederson S, O'Byrne P. A comparison of the efficacy and safety of inhaled corticosteroids in asthma. Allergy 1997;52 Suppl 39:1-34.
8. 8. Fauci A, Dale D, Balow J. Glucocorticosteroid therapy: mechanisms of action and clinical considerations. Ann Intern Med 1976:84:304-315.
9. 9. Blaiss MS, Herrod HG, Crawford LV, Lieberman PL. Beclomethasone dipropionate aerosol: hematologic and immunologic effects. Ann Allergy 1982;48:210-214.
10. 10. Evans PM, O'Connor BJ, Fuller RW, Barnes PJ, Chung KF. Effect of inhaled corticosteroids on peripheral blood eosinophil counts and density profiles in asthma. J Allergy Clin Immunol 1993;91:643-650.
11. 5+ B lymphocytes and other lymphocyte subsets in primary Sjögren's syndrome. Neth J Med 1992;40:158-164.
12. 12. Mygind N, Dahl R, Pedersen S, Thestrup-Pedersen K. Essential allergy. 2nd ed. Oxford: Blackwell, 1996.